BXP, owner of 6.7 million square feet of offices in San Francisco, is looking to fill them up with the help of small AI firms ...

Alumis Inc. will merge with a Southern California drug developer in a deal that extends the combined companies' cash into ...

Gladstone Institutes hopes to buy 103,400 square feet of life sciences research offices near its hub in San Francisco’s ...

Nektar Therapeutics named Brian Kotzin its interim chief medical officer, succeeding Mary Tagliaferri, who stepped down from the role citing personal reasons. Kotzin will assist in the search for a ...

Team coverage of the heavy rain falling across the San Francisco Bay Area Tuesday with more intense precipitation ahead.

CNBC's TechCheck brings you the latest in tech news from CNBC's 1 Market in the heart of San Francisco. There's no question about it, McDonald's is the most successful restaurant in the history of the ...

San Francisco's Board of Supervisors granted newly elected Mayor Daniel Lurie greater powers to expedite the city's response ...

Amazon and Google parent Alphabet are set to report earnings, along with other tech companies including AI darling Palantir, and chipmaker Advanced Micro Devices. Pharmaceutical firms Novo Nordisk, ...

Leaders from various commercial real estate firms sat on a panel this week to discuss the future of the industry in San Francisco after 2024’s record-high ...

A panel discussion during the JPMorgan conference earlier this month examined where oncology drug development is headed, driven in part by advances in diagnostic testing.

Adagene (ADAG) announced updated clinical data from ADG126 in microsatellite stable colorectal cancer, MSS CRC, at the ASCO Gastrointestinal ...